FI973804A - Levosimendaanin oraalisia koostumuksia - Google Patents

Levosimendaanin oraalisia koostumuksia

Info

Publication number
FI973804A
FI973804A FI973804A FI973804A FI973804A FI 973804 A FI973804 A FI 973804A FI 973804 A FI973804 A FI 973804A FI 973804 A FI973804 A FI 973804A FI 973804 A FI973804 A FI 973804A
Authority
FI
Finland
Prior art keywords
levosimendan
oral compositions
oral
compositions
Prior art date
Application number
FI973804A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973804A0 (fi
Inventor
Maarit Hannele Harjula
Ilkka Antero Larma
Saila Karin Antila
Lasse Antero Lehtonen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Priority to FI973804A priority Critical patent/FI973804A/fi
Publication of FI973804A0 publication Critical patent/FI973804A0/fi
Priority to MYPI98004329A priority patent/MY118156A/en
Priority to CA002304702A priority patent/CA2304702C/en
Priority to YUP-177/00A priority patent/RS49708B/sr
Priority to ES98946480T priority patent/ES2217580T3/es
Priority to IL13480298A priority patent/IL134802A/en
Priority to EEP200000187A priority patent/EE03854B1/xx
Priority to EP98946480A priority patent/EP1014987B1/en
Priority to JP2000513579A priority patent/JP4493840B2/ja
Priority to DE69822172T priority patent/DE69822172T2/de
Priority to KR1020007003095A priority patent/KR100762022B1/ko
Priority to EA200000360A priority patent/EA001647B1/ru
Priority to GEAP19985319A priority patent/GEP20032943B/en
Priority to AU93506/98A priority patent/AU732489B2/en
Priority to CZ2000919A priority patent/CZ294984B6/cs
Priority to ARP980104780A priority patent/AR013519A1/es
Priority to PL339461A priority patent/PL190862B1/pl
Priority to IDW20000565A priority patent/ID24486A/id
Priority to TR2000/00635T priority patent/TR200000635T2/xx
Priority to CNB988094673A priority patent/CN1149994C/zh
Priority to MXPA00002956A priority patent/MXPA00002956A/es
Priority to AT98946480T priority patent/ATE260659T1/de
Priority to PCT/FI1998/000753 priority patent/WO1999016443A1/en
Priority to US09/509,205 priority patent/US6355269B1/en
Priority to PT98946480T priority patent/PT1014987E/pt
Priority to SK384-2000A priority patent/SK283187B6/sk
Priority to SI9830645T priority patent/SI1014987T1/xx
Priority to BR9813213-0A priority patent/BR9813213A/pt
Priority to NZ503207A priority patent/NZ503207A/en
Priority to DK98946480T priority patent/DK1014987T3/da
Priority to HU0003757A priority patent/HUP0003757A3/hu
Publication of FI973804A publication Critical patent/FI973804A/fi
Priority to BG104250A priority patent/BG64746B1/bg
Priority to HR20000171A priority patent/HRP20000171B1/xx
Priority to YU17700A priority patent/YU17700A/sh
Priority to NO20001585A priority patent/NO320047B1/no
Priority to HK01102520A priority patent/HK1032001A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI973804A 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia FI973804A (fi)

Priority Applications (36)

Application Number Priority Date Filing Date Title
FI973804A FI973804A (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia
MYPI98004329A MY118156A (en) 1997-09-26 1998-09-21 Oral compositions of levosimendan.
HU0003757A HUP0003757A3 (en) 1997-09-26 1998-09-24 Oral pharmaceutical compositions of levosimendan
PL339461A PL190862B1 (pl) 1997-09-26 1998-09-24 Doustne kompozycje zawierające lewosimendan
CNB988094673A CN1149994C (zh) 1997-09-26 1998-09-24 左西孟旦口服组合物
ES98946480T ES2217580T3 (es) 1997-09-26 1998-09-24 Composiciones orales de levosimendan.
IL13480298A IL134802A (en) 1997-09-26 1998-09-24 Oral Bossimandan preparations for oral administration
EEP200000187A EE03854B1 (et) 1997-09-26 1998-09-24 Levosimendaani suu kaudu manustatavad segud
EP98946480A EP1014987B1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
JP2000513579A JP4493840B2 (ja) 1997-09-26 1998-09-24 レボシメンダンの経口組成物
DE69822172T DE69822172T2 (de) 1997-09-26 1998-09-24 Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
KR1020007003095A KR100762022B1 (ko) 1997-09-26 1998-09-24 레보시멘단의 경구용 조성물
EA200000360A EA001647B1 (ru) 1997-09-26 1998-09-24 Оральные композиции левосимендана
GEAP19985319A GEP20032943B (en) 1997-09-26 1998-09-24 Oral Composition of Levosimendan
AU93506/98A AU732489B2 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
CZ2000919A CZ294984B6 (cs) 1997-09-26 1998-09-24 Orální kompozice obsahující levosimendan
ARP980104780A AR013519A1 (es) 1997-09-26 1998-09-24 Composiciones orales de levosimendan
CA002304702A CA2304702C (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
IDW20000565A ID24486A (id) 1997-09-26 1998-09-24 Komposisi-komposisi oral dari levosimendan
TR2000/00635T TR200000635T2 (tr) 1997-09-26 1998-09-24 Levosimendan'ın oral kompozisyonları.
YUP-177/00A RS49708B (sr) 1997-09-26 1998-09-24 Oralne kompozicije levosimendana
MXPA00002956A MXPA00002956A (es) 1997-09-26 1998-09-24 Composiciones orales de levosimendan.
AT98946480T ATE260659T1 (de) 1997-09-26 1998-09-24 Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
PCT/FI1998/000753 WO1999016443A1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
US09/509,205 US6355269B1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
PT98946480T PT1014987E (pt) 1997-09-26 1998-09-24 Composicoes orais de levosimendano
SK384-2000A SK283187B6 (sk) 1997-09-26 1998-09-24 Orálna kompozícia obsahujúca levosimendan
SI9830645T SI1014987T1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
BR9813213-0A BR9813213A (pt) 1997-09-26 1998-09-24 Composições orais de levosimendan
NZ503207A NZ503207A (en) 1997-09-26 1998-09-24 Oral compositions of crystalline levosimendan
DK98946480T DK1014987T3 (da) 1997-09-26 1998-09-24 Orale præparater med levosimendan
BG104250A BG64746B1 (bg) 1997-09-26 2000-03-16 Състав за орално приложение, съдържащ левосимендан
HR20000171A HRP20000171B1 (en) 1997-09-26 2000-03-23 Oral compositions of levosimendan
YU17700A YU17700A (sh) 1997-09-26 2000-03-24 Oralne kompozicije levosimendana
NO20001585A NO320047B1 (no) 1997-09-26 2000-03-27 Sammensetning for oral administrering
HK01102520A HK1032001A1 (en) 1997-09-26 2001-04-10 Oral compositions of levosimendan.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI973804A FI973804A (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia

Publications (2)

Publication Number Publication Date
FI973804A0 FI973804A0 (fi) 1997-09-26
FI973804A true FI973804A (fi) 1999-03-27

Family

ID=8549609

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973804A FI973804A (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia

Country Status (36)

Country Link
US (1) US6355269B1 (zh)
EP (1) EP1014987B1 (zh)
JP (1) JP4493840B2 (zh)
KR (1) KR100762022B1 (zh)
CN (1) CN1149994C (zh)
AR (1) AR013519A1 (zh)
AT (1) ATE260659T1 (zh)
AU (1) AU732489B2 (zh)
BG (1) BG64746B1 (zh)
BR (1) BR9813213A (zh)
CA (1) CA2304702C (zh)
CZ (1) CZ294984B6 (zh)
DE (1) DE69822172T2 (zh)
DK (1) DK1014987T3 (zh)
EA (1) EA001647B1 (zh)
EE (1) EE03854B1 (zh)
ES (1) ES2217580T3 (zh)
FI (1) FI973804A (zh)
GE (1) GEP20032943B (zh)
HK (1) HK1032001A1 (zh)
HR (1) HRP20000171B1 (zh)
HU (1) HUP0003757A3 (zh)
ID (1) ID24486A (zh)
IL (1) IL134802A (zh)
MX (1) MXPA00002956A (zh)
MY (1) MY118156A (zh)
NO (1) NO320047B1 (zh)
NZ (1) NZ503207A (zh)
PL (1) PL190862B1 (zh)
PT (1) PT1014987E (zh)
RS (1) RS49708B (zh)
SI (1) SI1014987T1 (zh)
SK (1) SK283187B6 (zh)
TR (1) TR200000635T2 (zh)
WO (1) WO1999016443A1 (zh)
YU (1) YU17700A (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
FI980902A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI980901A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20000577A0 (fi) * 2000-03-13 2000-03-13 Orion Yhtymae Oy Pyridatsinyylifenyylihydratsoneja
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
HUP0501030A3 (en) * 2000-12-22 2008-04-28 Baxter Int Method for preparing submicron particle suspensions
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
WO2011007123A1 (en) * 2009-07-14 2011-01-20 Cipla Limited Process for preparing levosimendan and intermediates for use in the process
CN104418810A (zh) * 2013-09-04 2015-03-18 北京博时安泰科技发展有限公司 一种左西孟旦的合成新路线
CN103554032A (zh) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法
ITMI20132185A1 (it) * 2013-12-23 2015-06-24 Edmond Pharma Srl Polimorfi di levosimendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
US11969424B2 (en) 2019-12-16 2024-04-30 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
CN111548310B (zh) * 2020-05-12 2021-07-02 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型及其制备方法
CN111718299B (zh) * 2020-07-23 2023-03-10 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型b及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
CN1271282A (zh) 2000-10-25
PL339461A1 (en) 2000-12-18
RS49708B (sr) 2007-12-31
AU9350698A (en) 1999-04-23
SK3842000A3 (en) 2000-09-12
ATE260659T1 (de) 2004-03-15
HRP20000171B1 (en) 2009-06-30
KR20010030679A (ko) 2001-04-16
BG64746B1 (bg) 2006-02-28
NO320047B1 (no) 2005-10-17
IL134802A (en) 2004-01-04
CA2304702A1 (en) 1999-04-08
KR100762022B1 (ko) 2007-09-28
NZ503207A (en) 2001-04-27
BR9813213A (pt) 2000-08-29
US6355269B1 (en) 2002-03-12
IL134802A0 (en) 2001-04-30
HK1032001A1 (en) 2001-07-06
CZ294984B6 (cs) 2005-04-13
HUP0003757A3 (en) 2001-07-30
EE200000187A (et) 2001-04-16
GEP20032943B (en) 2003-04-25
CZ2000919A3 (cs) 2000-09-13
BG104250A (en) 2000-12-29
NO20001585D0 (no) 2000-03-27
TR200000635T2 (tr) 2000-09-21
PL190862B1 (pl) 2006-02-28
SI1014987T1 (en) 2004-08-31
FI973804A0 (fi) 1997-09-26
DE69822172D1 (de) 2004-04-08
ID24486A (id) 2000-07-20
AR013519A1 (es) 2000-12-27
EP1014987B1 (en) 2004-03-03
YU17700A (sh) 2002-10-18
CA2304702C (en) 2007-09-04
EA001647B1 (ru) 2001-06-25
NO20001585L (no) 2000-03-27
PT1014987E (pt) 2004-06-30
DK1014987T3 (da) 2004-05-24
WO1999016443A1 (en) 1999-04-08
ES2217580T3 (es) 2004-11-01
MY118156A (en) 2004-09-30
AU732489B2 (en) 2001-04-26
EA200000360A1 (ru) 2000-10-30
CN1149994C (zh) 2004-05-19
HRP20000171A2 (en) 2000-12-31
DE69822172T2 (de) 2005-02-24
EE03854B1 (et) 2002-10-15
JP2001517702A (ja) 2001-10-09
HUP0003757A2 (hu) 2001-05-28
EP1014987A1 (en) 2000-07-05
MXPA00002956A (es) 2003-05-19
SK283187B6 (sk) 2003-03-04
JP4493840B2 (ja) 2010-06-30

Similar Documents

Publication Publication Date Title
FI973804A (fi) Levosimendaanin oraalisia koostumuksia
ID20233A (id) Komposisi oral
ID19097A (id) Komposisi-komposisi oral
ID26720A (id) Komposisi oral
FI963421A0 (fi) Oraalisia apuainekoostumuksia
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
IS2325B (is) Örgerðar samsetningar epleróns
BR9508844A (pt) Composição oral
TR199501447A2 (tr) Oral bilesimler.
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
BR9506536A (pt) Composição oral
DE69838290D1 (de) Vernetzungszusammensetzungen
NO962491D0 (no) Orale formuleringer av S(+)-etodolac
BR9510467A (pt) Composições orais
DK1023035T3 (da) Mundplejemiddel
DE69926907T2 (de) Bleichungzusammensetzungen
DE69828097D1 (de) Mundpflegezusammensetzung
ID20466A (id) Komposisi oral
BR9510307A (pt) Composições orais
BR9606974A (pt) Composições orais
ID16838A (id) Komposisi dekafluoropentana
DE69901022T2 (de) Mundpflegezusammensetzungen
ID19246A (id) Komposisi oral antikalkulus
EE04220B1 (et) Kontrollitud vabanemisega levosimendani peroraalsed koostised

Legal Events

Date Code Title Description
FD Application lapsed